Optical Coherence Tomography Predictors for a Favorable Vascular Response to Statin Therapy.

Akihiro Nakajima,Yoshiyasu Minami,Makoto Araki,Osamu Kurihara,Tsunenari Soeda,Taishi Yonetsu,Zhao Wang,Iris McNulty,Hang Lee,Sunao Nakamura,Ik‐Kyung Jang

DOI: https://doi.org/10.1161/jaha.120.018205

IF: 6.106

2020-12-23

Journal of the American Heart Association

Abstract:Background Specific plaque phenotypes that predict a favorable response to statin therapy have not been systematically studied. This study aimed to identify optical coherence tomography predictors for a favorable vascular response to statin therapy. Methods and Results Patients who had serial optical coherence tomography imaging at baseline and at 6 months were included. Thin‐cap area (defined as an area with fibrous cap thickness <200 μm) was measured using a 3‐dimensional computer‐aided algorithm, and changes in the thin‐cap area at 6 months were calculated. A favorable vascular response was defined as the highest tertile in the degree of reduction of the thin‐cap area. Macrophage index was defined as the product of the average macrophage arc and length of the lesion with macrophage infiltration. Layered plaque was defined as a plaque with 1 or more layers of different optical density. In 84 patients, 140 nonculprit lipid plaques were identified. In multivariable analysis, baseline thin‐cap area (odds ratio [OR] 1.442; 95% CI, 1.024–2.031, P =0.036), macrophage index (OR, 1.031; 95% CI, 1.002–1.061, P =0.036), and layered plaque (OR, 2.767; 95% CI, 1.024–7.479, P =0.045) were identified as the significant predictors for a favorable vascular response. Favorable vascular response was associated with a decrease in the macrophage index. Conclusions Three optical coherence tomography predictors for a favorable vascular response to statin therapy have been identified: large thin‐cap area, high macrophage index, and layered plaque. Favorable vascular response to statin was correlated with signs of decreased inflammation. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538. Nonstandard Abbreviations and Acronyms FC fibrous cap FCT fibrous cap thickness TCFA thin‐cap fibroatheroma Clinical Perspective What Is New? Plaques with features of vulnerability (large thin‐cap area, high macrophage index, and layered plaque) respond more favorably to statin therapy. Significant correlations are observed between the change in the macrophage index and the change in thin‐cap area. The prevalence of layered (vulnerable) plaques significantly increases only in plaques with increased macrophage index. What Are the Clinical Implications? Statin therapy should be started immediately in patients who have optical coherence tomography predictors for a favorable response (large thin‐cap area, high macrophage index, and layered plaque). For patients who have evidence of persistent active inflammation, additional therapies such as anti‐inflammatory agents may need to be considered. Acute coronary syndrome (ACS) is the leading cause of morbidity and mortality in the world. 1 The most common mechanism of ACS is rupture of a lipid plaque. 2 Optical coherence tomography (OCT) studies have revealed that fibrous cap thickness (FCT) is one of the most important determinants of plaque vulnerability. 3 , 4 A previous study reported that 95% of ruptured plaques in patients had FCT <188 μm. 5 Recent studies have demonstrated that statin therapy stabilizes high‐risk plaques by increasing FCT and reducing thin‐cap area. 6 , 7 Recent studies have also shown that layered plaque is a signature of previous plaque destabilization, followed by healing, and is associated with panvascular inflammation and vulnerability. 8 , 9 Thus, the presence of a layered phenotype may be associated with a vascular response to statin therapy because statins are -Abstract Truncated-

cardiac & cardiovascular systems